002589 瑞康医药
2025/09 - 九个月
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资528,488-0.64%531,901655,388435,948638,749
投资性房地产677,74615.45%587,042605,263625,422644,276
固定资产1,723,766-10.50%1,925,9311,845,5651,975,3471,922,303
在建工程310,4971.03%307,339429,340315,367549,585
无形资产519,54717.84%440,890552,391624,208478,346
商誉146,6680.00%146,668146,668146,685620,267
其他非流动资产979,214-3.41%1,013,831935,5991,389,680871,241
4,885,925-1.37%4,953,6025,170,2135,512,6575,724,766

流动资产
货币资金4,241,083-14.91%4,984,0975,060,7875,340,2124,578,740
应收账款3,733,258-3.41%3,865,2173,762,9884,112,36910,285,101
存货692,925-5.69%734,7411,119,070954,5152,067,938
其他流动资产1,775,76218.40%1,499,8151,596,2482,412,4603,740,430
10,443,029-5.78%11,083,87011,539,09312,819,55620,672,209

流动负债
短期借款5,302,031-13.03%6,096,6856,556,0613,839,8354,165,027
应付票据1,110,42084.03%603,383448,5995,157,3596,435,746
应付帐款2,351,738-15.38%2,779,0543,274,0302,557,3923,355,303
其他流动负债633,85036.25%465,222482,428913,8502,551,708
9,398,039-5.49%9,944,34410,761,11812,468,43716,507,784
流动资产净值1,044,990-8.30%1,139,526777,975351,1194,164,425
资产总额减流动负债5,930,915-2.66%6,093,1285,948,1885,863,7779,889,191

非流动负债
长期借款425,39830.06%327,081261,27467,20048,500
应付债券0--0000
其他非流动负债51,336-10.50%57,35749,93745,244147,534
476,73524.01%384,438311,211112,444196,034

总权益
    实收股本1,504,7100.00%1,504,7101,504,7101,504,7101,504,710
    储备项目3,844,263-4.93%4,043,7773,943,0833,902,6226,062,325
股东权益5,348,974-3.60%5,548,4885,447,7945,407,3327,567,036
非控股权益105,206-34.33%160,202189,183344,0002,126,121